Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 353 - 360 of 11616 results
SCOTUS Grants Certiorari to Hear NVIDIA Fraud Appeal on PSLRA Pleading Standard
June 24, 2024| Blog| Viewpoint
Senators Introduce Bill for AI Procurement and Use by Federal Agencies — AI: The Washington Report
June 21, 2024| Article| Viewpoint
A New Dawn (Maybe) for California Employers: State and Business Groups Strike Deal on PAGA Reform
June 20, 2024| Blog| Viewpoint
Court Split Creates Uncertainty Around Enforcement of the No Surprises Act
June 20, 2024| Blog| Viewpoint
Trade Secrets Strategies in Early-Stage R&D
June 18, 2024| News
PBM Takeaways From Proposed Telehealth Flexibility Bill
June 18, 2024| News
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.